Hikma Pharmaceuticals
HIK.L
#2667
Rank
S$7.03 B
Marketcap
$31.71
Share price
1.46%
Change (1 day)
7.84%
Change (1 year)

Earnings for Hikma Pharmaceuticals (HIK.L)

Earnings in 2023: S$0.37 Billion

According to Hikma Pharmaceuticals 's latest financial reports the company's current earnings are S$2.87 Billion. In 2023 the company made an earning of S$0.37 Billion, an increase over its 2022 earnings that were of S$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hikma Pharmaceuticals from 2002 to 2023

Annual earnings

Year Earnings Change
2023S$0.37 B20.6%
2022S$0.31 B-57.17%
2021S$0.73 B-2.51%
2020S$0.75 B13.65%
2019S$0.66 B67.58%
2018S$0.39 B-139.7%
2017-S$1 Billion-451.43%
2016S$0.28 B-33.96%
2015S$0.42 B-12.15%
2014S$0.48 B21.48%
2013S$0.40 B125.76%
2012S$0.17 B40.59%
2011S$0.12 B-22.39%
2010S$0.16 B27.63%
2009S$0.12 B48.03%
2008S$86.15 M-23.58%
2007S$0.11 B10.84%
2006S$0.10 B17.37%
2005S$86.66 M9.12%
2004S$79.41 M98.92%
2003S$39.92 M55.38%
2002S$25.69 M